U.S. Gas Utilities Stock News

FIGS added to defensive indexes, drawing fresh attention to the stock FIGS (FIGS) has been added to both the Russell 2000 Growth Defensive Index and the Russell 2000 Defensive Index, an event that often brings more attention from index-linked products and benchmark-focused investors. This shift in index membership can matter for FIGS because many institutional portfolios track or reference Russell benchmarks, which can influence trading volumes, liquidity, and how the stock is compared with...

Rambus Inc. recently announced its DDR5 9600 Server RDIMM chipset, built around the 6th Generation RCD06 and supporting modules up to 9,600 MT/s to meet the bandwidth and power demands of AI and other data-intensive data center workloads. By tightly integrating clocking, power management and thermal monitoring into a single chipset, Rambus is aiming to simplify RDIMM design for server manufacturers while improving reliability at very high DDR5 speeds. We’ll now examine how this...

General Mills reported fiscal fourth-quarter 2026 results showing sales of US$4,609.6 million but a net loss of US$2,007.9 million, driven largely by US$1,750.0 million of goodwill and intangible asset impairments, and for the full year recorded sales of US$18,424.6 million with a net loss of US$87.6 million versus a profit a year earlier. Despite swinging to a loss, the company maintained its long-standing dividend policy with a US$0.61 quarterly payout and paused buybacks this past...

Fortinet (FTNT) is back in focus after being dropped from the Russell 1000 Growth Defensive and Russell 1000 Defensive indices. This shift puts recent earnings driven enthusiasm in a different context. See our latest analysis for Fortinet. Despite the index removals and some recent share price softness, Fortinet has seen strong momentum build over the year, with a 90 day share price return of 94.28% and a 5 year total shareholder return of 206.27%, indicating that longer term holders have...

What Stride’s Index Additions Could Mean for Investors Stride (LRN) has been added to several Russell value and small cap benchmarks, a shift that often attracts attention from index-tracking funds and raises questions about how the stock fits into diversified portfolios. For you as an investor, the key takeaway is that Stride now appears in multiple value oriented indices, including the Russell 2000 Value Defensive Index and various Russell value benchmarks covering the small and broad US...

BridgeBio Pharma recently reported positive Phase 3 data for oral infigratinib in children with achondroplasia and published new post‑hoc analyses in Circulation: Heart Failure suggesting kidney-protective effects of acoramidis (Attruby) in transthyretin amyloid cardiomyopathy, alongside securing up to US$1.00 billion in preferred equity financing and multiple index reclassifications. Together, these clinical, regulatory and financing developments reinforce BridgeBio’s push to expand...

Ichor Holdings, Ltd. was recently removed from multiple Russell value and microcap indices while being added to several Russell growth benchmarks, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, and 3000E Growth indices. This shift signals that index providers now classify Ichor more as a growth-oriented semiconductor equipment supplier than a value or microcap name, which could influence how institutional investors and quantitative funds view the stock. We’ll now examine how...

In late June 2026, Nurix Therapeutics, Inc. was added to multiple Russell growth and small-cap benchmarks, including the Russell 2000 Growth and Russell 2500 Growth indices. This broad inclusion across several Russell growth-oriented indices can increase the company’s visibility with institutional investors and index-tracking funds. We’ll now examine how Nurix’s broad addition across Russell growth benchmarks may shape its investment narrative and potential investor attention. AI is about to...

Why the latest Azenta event matters for investors Azenta (AZTA) has just completed the previously announced sale of its B Medical Systems business to Thelema S.à r.l. This represents a portfolio shift that places more emphasis on its core life sciences operations. For investors, this completed transaction creates a fresh reference point to reassess how Azenta’s sample management and multiomics segments, which together generated US$596.5 million in revenue, compare with the company’s current...

Recent coverage around Par Pacific Holdings (PARR) has focused on its ability to keep refining margins resilient through flexible crude sourcing and regional advantages, while the stock trades at a discount to the broader industry. See our latest analysis for Par Pacific Holdings. The recent strength in Par Pacific Holdings' refining story is being reflected in the market, with a 1-day share price return of 11.57% at US$68.57 and a year-to-date share price return of 91.43%. The 1-year total...

Moog Inc. has expanded its Board of Directors from nine to ten members and, effective July 1, 2026, elected Carl R. Christenson as a Class A director, adding a leader with extensive experience from Altra Industrial Motion Corp. and IDEX Corporation. This appointment brings in decades of industrial and motion-control expertise that could influence Moog’s governance, capital allocation priorities, and long-term business focus. We’ll now examine how adding Carl R. Christenson to Moog’s expanded...

San Diego Gas & Electric (SDG&E), a Sempra subsidiary, recently reported that more than 350,000 residential customers now generate their own power through rooftop solar, after streamlining its interconnection process to connect systems to the grid more quickly. This milestone highlights SDG&E's role in advancing grid modernization and integrating customer-generated renewable energy at one of the highest adoption rates in the United States. We’ll now examine how SDG&E’s rapid rooftop solar...

Why recent contract wins matter for TechnipFMC stock TechnipFMC (FTI) has landed a run of sizeable offshore contracts with Equinor, Eni and Vår Energi, concentrating new work in subsea projects across Norway, the North Sea and Côte d’Ivoire. For investors, these awards highlight fresh order intake in the company’s core subsea business, with individual contract values ranging from a “significant” US$75 million to US$250 million and up to US$1 billion for the largest award. See our latest...

CoStar Group has launched its commercial real estate intelligence platform in France, using its acquisitions of BureauxLocaux and Business Immo plus extensive local research to offer a unified database of properties, availabilities, comparables, news, and analytics tailored to the French market. This rollout gives French market participants access to a comprehensive dataset covering hundreds of thousands of assets and tenants, reflecting CoStar’s multibillion‑dollar, decades-long investment...

On 27 June 2026, Chemed Corporation (NYSE: CHE) was removed from multiple Russell growth and defensive indices, including the Russell 1000 Growth and Russell 3000 Growth benchmarks, following the latest index reconstitution. This broad index exclusion may alter how passive and benchmark-aware investors gain exposure to Chemed, potentially affecting its shareholder base composition and trading patterns. We’ll now examine how Chemed’s widespread removal from key Russell growth indices...

Akamai Technologies (AKAM) is back in focus after being selected as the security backbone for World Wide Technology’s ARMOR framework for AI operations, while also earning a 2026 Gartner Customers’ Choice recognition for edge distribution platforms. See our latest analysis for Akamai Technologies. Recent AI security partnerships and customer recognition appear to be catching investor attention, with Akamai Technologies’ share price up 10.67% over one day and 15.47% over ninety days. Its one...

In late June 2026, Ecolab Inc. (NYSE:ECL) was removed from several Russell growth indices, including the Russell Top 200 Growth and Russell 1000 Growth benchmarks. This index reshuffle coincides with fresh analyst attention on Ecolab’s pricing actions, which are expected to help counter commodity cost inflation and support organic sales growth. Next, we’ll examine how Ecolab’s pricing power, highlighted in recent commentary, reshapes the company’s existing investment narrative and...

Buckle (BKE) is back in focus after being removed from several Russell value and small cap indices on June 27. This change can reshape trading flows and how some institutional investors view the stock. See our latest analysis for Buckle. The share price has come under pressure recently, with Buckle down 7.04% over the past month and 25.58% over 90 days, while the year to date share price return is down 23.02% at a last close of US$41.46. However, the 3 year total shareholder return of 56.13%...

Affiliated Managers Group (AMG) stock continues to draw interest after recent trading, with shares closing at US$356.27 and posting returns over the past week, month, past 3 months, and year that some investors are watching closely. See our latest analysis for Affiliated Managers Group. Against this backdrop, Affiliated Managers Group's recent share price pullback of 0.96% over the last trading day comes after steady momentum, with a 90 day share price return of 24.43% and a 1 year total...

Index additions put LPL Financial Holdings back in the spotlight LPL Financial Holdings (LPLA) has been added to several Russell value benchmarks, a shift that is drawing fresh attention to the stock and intensifying debate over what investors should pay for it. The company now sits in the Russell 3000 Value, Russell 1000 Value, Russell Midcap Value, Russell 3000E Value, and Russell Small Cap Comp Value benchmarks. This places LPL Financial Holdings in front of a broader group of index...

NewAmsterdam Pharma announced that it will present data at the 2026 Alzheimer’s Association International Conference in London on obicetrapib, an oral, low-dose CETP inhibitor, showing statistically significant effects on Alzheimer’s disease biomarkers in cardiovascular patients from the Phase 3 BROADWAY trial. The analyses highlight reduced p-tau217 levels, particularly in ApoE4 carriers, hinting at a potential role for obicetrapib in early Alzheimer’s disease prevention alongside its...

In late June 2026, BioCryst Pharmaceuticals said it would discontinue its internal discovery programs and close its Birmingham, Alabama Discovery Center of Excellence by the end of 2026, shifting its rare disease pipeline development toward external innovation and partnerships. This move marks a major change in how BioCryst sources future drug candidates, trading in-house research infrastructure for a more flexible, partner-driven model that could reshape its long-term pipeline mix. Next,...

Why Dillard's Stock Is Back in Focus Dillard's (DDS) is drawing investor attention after first quarter results showed firmer sales and margins, supported by healthy consumer demand, refreshed merchandise assortments, and ongoing investment in its omnichannel retail model. See our latest analysis for Dillard's. Dillard's share price has cooled after its recent update, with the stock down 15.6% over the past month and 18.9% year to date, even though the 1 year total shareholder return is 24.4%...

On 27 June 2026, Mirion Technologies, Inc. (NYSE:MIR) was added to a range of Russell indices, including Russell 3000 and Russell 2000 value and defensive benchmarks, broadening its index footprint after the reconstitution. This broad inclusion across value, growth, and defensive small-cap indices places Mirion on the radar of a wider base of index-tracking and quantitatively driven investors. We’ll now examine how Mirion’s addition to multiple Russell value and defensive indices may...